| Source: |
| Type: |
| Tissue superoxide dismutases (T‐SOD)—referring generally to the family of SOD enzymes (e.g., SOD1, SOD2, and SOD3) responsible for detoxifying reactive oxygen species (ROS)—in the context of cancer. Superoxide dismutases (SODs) are antioxidant enzymes that catalyze the conversion of the superoxide anion (O₂•–) into hydrogen peroxide and oxygen. Oxidative stress plays a dual role in cancer: while moderate levels of ROS can promote cell proliferation and survival signaling, excessive ROS can cause cellular damage and trigger apoptosis. Alterations in SOD expression may therefore contribute to either tumor suppression or promotion depending on the context: • Upregulation of SOD can protect normal and cancer cells against oxidative damage, sometimes supporting tumor cell survival under stress. • Conversely, low SOD activity may lead to increased ROS, DNA damage, and mutagenesis, thereby contributing to tumor initiation. – The specific impact of changes in T‐SOD levels often depends on the isoform in question, the type of cancer, and the balance with other oxidative stress regulators. |
| 1204- | MET, | Metformin induces ferroptosis through the Nrf2/HO-1 signaling in lung cancer |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | H1299 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1046 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid